Key result
In male elite athletes, traditional ECG voltage criteria lacked diagnostic value for left ventricular hypertrophy, whereas in female athletes, voltage and product criteria showed acceptable discriminatory capabilities for left ventricular mass.
Why the study?
In athletes, ECG criteria for LVH have been validated almost exclusively in men using echocardiography, and sex-specific cardiac magnetic resonance validation is lacking.
Do ECG-LVH criteria accurately correlate with and detect CMR-derived left ventricular hypertrophy in male and female elite athletes?
Cross-Sectional (n=209)
No
Do ECG-LVH criteria accurately correlate with and detect CMR-derived left ventricular hypertrophy in male and female elite athletes?
Standard ECG criteria for left ventricular hypertrophy lack diagnostic value in male elite athletes but may have moderate diagnostic potential in female elite athletes.
Answers are grounded in this paper and cite their sources.
ECG-LVH criteria should not guide LVH assessment in male athletes; leaves open moderate utility in females pending prospective validation.
BACKGROUND: In athletes, left ventricular hypertrophy (LVH) criteria based on electrocardiograms (ECGs) have been validated almost exclusively in men using echocardiography. Sex-specific cardiac magnetic resonance (CMR) validation is lacking. OBJECTIVE: To evaluate ECG-LVH criteria against contrast-enhanced CMR in male and female elite athletes. METHODS: Cross-sectional study in healthy elite athletes. Eight ECG-LVH criteria of voltages and products and QRS duration were quantified using automated ECG analysis, and compared to CMR-derived LVH indicators (indexed left ventricular mass (LVM) and maximum left ventricular wall thickness (maxLVWT). Primary metrics of interest were sex-specific correlations (ρ) between ECG-LVH criteria and LVM/maxLVWT. Secondary metrics included discriminative performance (AUROC) and sensitivity at a 95%-specificity level for detecting increased LVM or maxLVWT. RESULTS: Among 209 elite athletes (median age 25, 45% women), men more frequently met one or more voltage criteria than women (64% vs 45%, P = .010). In men, no ECG-LVH criteria showed meaningful correlations or discriminative performance for LVM or maxLVWT. Only QRS duration demonstrated discriminative performance (AUROC: LVM 0.67; maxLVWT 0.74). In women, all voltage and product criteria correlated with LVM (ρ = 0.25-0.45) with acceptable discrimination (AUROC: 0.63-0.73). Peguero-Lo Presti, Cornell-, and Modified Sum of 12-Lead Product showed moderate performance (sensitivities: 24%-29%) at 95% specificity in female athletes. Overall, increased precordial QRS voltages were independently correlated with lower extracellular volume (β = -0.3 mV per %ECV, P < .001). CONCLUSION: In elite athletes, ECG-LVH criteria, except for QRS duration, lack diagnostic value for LVH in men. Voltage criteria may have diagnostic potential in women.
No takes yet. Share an insight, caveat, or question.
Diepen et al. (2025) conducted a cross-sectional in Left ventricular hypertrophy in elite athletes (n=209). Electrocardiographic (ECG) criteria for left ventricular hypertrophy vs. Cardiac magnetic resonance (CMR) imaging was evaluated on Sex-specific correlations (r) between ECG-LVH criteria and CMR-derived indexed left ventricular mass (LVM) and maximum left ventricular wall thickness (maxLVWT). In male elite athletes, traditional ECG voltage criteria lacked diagnostic value for left ventricular hypertrophy, whereas in female athletes, voltage and product criteria showed acceptable discriminatory capabilities for left ventricular mass.
Synapse has enriched 10 related papers. Consider them for comparative context: